NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis Patients

Not Yet RecruitingN/A

Sponsor: Assiut University

Conditions: Rheumatoid Arthritis, Interstitial Lung Disease

Interventions: Calprotectin Level

Countries: Egypt

\- Assess Krebs von den Lungen-6 (KL-6) and Calprotectin as novel biomarkers for diagnosis of ILD among Rheumatoid arthritis patients

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Confirmed diagnosis of Rheumatoid arthritis, age \> 18 years.

Exclusion Criteria:

* Patients who refuse to participate in the study,
* Patients with evidence of worsening or exacerbation of RA over the previous 6 months,
* concomitant diagnosis of an active neoplasia, or
* patients who had previously received radiotherapy,
* End organ failure.

Locations (1)

Asyut, Egypt